Cargando…

Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma

PURPOSE: To identify tissue microRNAs predictive of sunitinib activity in patients with metastatic renal-cell-carcinoma (MRCC) and to evaluate in vitro their mechanism of action in sunitinib resistance. METHODS: We screened 673 microRNAs using TaqMan Low-density-Arrays (TLDAs) in tumors from MRCC pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prior, Celia, Perez-Gracia, Jose Luis, Garcia-Donas, Jesus, Rodriguez-Antona, Cristina, Guruceaga, Elizabeth, Esteban, Emilio, Suarez, Cristina, Castellano, Daniel, del Alba, Aránzazu González, Lozano, Maria Dolores, Carles, Joan, Climent, Miguel Angel, Arranz, Jose Angel, Gallardo, Enrique, Puente, Javier, Bellmunt, Joaquim, Gurpide, Alfonso, Lopez-Picazo, Jose Maria, Hernandez, Alvaro Gonzalez, Mellado, Begoña, Martínez, Esther, Moreno, Fernando, Font, Albert, Calvo, Alfonso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901669/ https://www.ncbi.nlm.nih.gov/pubmed/24475095 http://dx.doi.org/10.1371/journal.pone.0086263

Ejemplares similares

Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients
por: Liu, Xiaoyan, et al.
Publicado: (2016)

Epithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma
por: Font, Albert, et al.
Publicado: (2021)

Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
por: Alfaro, C, et al.
Publicado: (2009)

Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
por: Diekstra, Meta H. M., et al.
Publicado: (2015)

Randomized Pharmacokinetic Study Comparing Subcutaneous and Intravenous Palonosetron in Cancer Patients Treated with Platinum Based Chemotherapy
por: Sadaba, Belen, et al.
Publicado: (2014)

Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array
por: Perez-Gracia, J L, et al.
Publicado: (2009)

The Dynamic Use of EGFR Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer Patients
por: Macías, Mónica, et al.
Publicado: (2019)

Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy
por: Esteban, Emilio, et al.
Publicado: (2021)

A pipeline for metabarcoding and diet analysis from fecal samples developed for a small semi-aquatic mammal
por: Hawlitschek, Oliver, et al.
Publicado: (2018)

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
por: Hsu, Yi-Fan, et al.
Publicado: (2010)

Size increase without genetic divergence in the Eurasian water shrew Neomys fodiens
por: Balmori-de la Puente, Alfonso, et al.
Publicado: (2019)

Publisher Correction: Size increase without genetic divergence in the Eurasian water shrew Neomys fodiens
por: Balmori-de la Puente, Alfonso, et al.
Publicado: (2020)

Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE
por: Puente, Javier, et al.
Publicado: (2020)

SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
por: Méndez-Vidal, María José, et al.
Publicado: (2023)

SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)
por: Valderrama, Begoña P., et al.
Publicado: (2022)

Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma
por: Puente, Javier, et al.
Publicado: (2017)

Evaluating the use of non‐invasive hair sampling and ddRAD to characterize populations of endangered species: Application to a peripheral population of the European mink
por: Balmori‐de la Puente, Alfonso, et al.
Publicado: (2023)

Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy
por: Grande, E., et al.
Publicado: (2022)

Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries
por: Porta, Camillo, et al.
Publicado: (2014)

IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
por: Xu, C-F, et al.
Publicado: (2015)

Situación actual del paciente pediátrico con patología crónica compleja: una experiencia entre atención primaria y hospitalaria
por: Monroy Tapiador, Miguel Ángel, et al.
Publicado: (2021)

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib
por: Jiménez-Fonseca, Paula, et al.
Publicado: (2018)

Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature
por: Guillem, Vicente, et al.
Publicado: (2015)

Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group
por: González-del-Alba, Aránzazu, et al.
Publicado: (2022)

Mapping of SARS-CoV-2 in Waldeyer’s lymphatic ring and visceral biopsies: the age and the illness duration’s impact()
por: Alba, Jose Ramón, et al.
Publicado: (2023)

Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group
por: Rubio-Briones, José, et al.
Publicado: (2021)

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib
por: Cebrián, Arancha, et al.
Publicado: (2017)

Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib
por: Diekstra, Meta H. M., et al.
Publicado: (2022)

Reverse-Coded Items Do Not Work in Spanish: Data From Four Samples Using Established Measures
por: Venta, Amanda, et al.
Publicado: (2022)

The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer
por: Martínez-Bosch, Neus, et al.
Publicado: (2016)

A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide
por: Fernandez‐Perez, María P., et al.
Publicado: (2022)

Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
por: Patiño-García, Ana, et al.
Publicado: (2021)

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting
por: Garrido Siles, Marga, et al.
Publicado: (2022)

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
por: Lainez, Nuria, et al.
Publicado: (2016)

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
por: Lindskog, Magnus, et al.
Publicado: (2022)

Evaluation of New Antimicrobial Materials Incorporating Ethyl Lauroyl Arginate or Silver into Different Matrices, and Their Safety in Use as Potential Packaging
por: Manso, Sofía, et al.
Publicado: (2021)

Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
por: Castellano, D., et al.
Publicado: (2009)

Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation
por: Alfaro, Carlos, et al.
Publicado: (2011)

Design, Calibration, and Application of a Robust, Cost-Effective, and High-Resolution Lensless Holographic Microscope
por: Picazo-Bueno, Jose Angel, et al.
Publicado: (2022)

Single-shot wavelength-multiplexed phase microscopy under Gabor regime in a regular microscope embodiment
por: Micó, Vicente, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_itb8soijks896fctm23sgmo2hp